Income taxes (Tables)
|
12 Months Ended |
Dec. 31, 2017 |
| Text block1 [abstract] |
|
| Components of Tax Provision (Recovery) |
The components of the income tax
provision (recovery) include:
|
|
|
|
|
|
|
|
|
| |
|
2017 |
|
|
2016 |
|
|
Current
|
|
$ |
— |
|
|
$ |
— |
|
|
Deferred
|
|
|
298 |
|
|
|
(568 |
) |
|
|
|
|
|
|
|
|
|
|
|
$ |
298 |
|
|
$ |
(568 |
) |
|
|
| Reconciliation of Combined Canadian Federal and Provincial Statutory Income Tax Rate to Effective Tax Rate |
The reconciliation of the combined Canadian federal
and provincial statutory income tax rate of 26.5% (2016 - 26.5%) to
the effective tax rate is as follows:
|
|
|
|
|
|
|
|
|
| |
|
2017 |
|
|
2016 |
|
|
Income before income taxes
|
|
$ |
2,789 |
|
|
$ |
(1,758 |
) |
|
Combined statutory tax rate
|
|
|
26.5 |
% |
|
|
26.5 |
% |
|
Theoretical tax expense (recovery)
|
|
$ |
739 |
|
|
$ |
(466 |
) |
|
Non-deductible
expense:
|
|
|
|
|
|
|
|
|
|
Stock-based payments
|
|
|
494 |
|
|
|
81 |
|
|
Non-taxable income:
|
|
|
|
|
|
|
|
|
|
Non-taxable portion of
capital gains
|
|
|
(762 |
) |
|
|
— |
|
|
Effect of provincial tax rate difference
|
|
|
5 |
|
|
|
4 |
|
|
Changes in unrecognized deferred tax assets
|
|
|
(178 |
) |
|
|
(187 |
) |
|
|
|
|
|
|
|
|
|
|
Income tax expense (recovery)
|
|
$ |
298 |
|
|
$ |
(568 |
) |
|
|
|
|
|
|
|
|
|
|
| Summary of components of net deferred tax liability |
The components of deferred tax are summarized
below. Deferred tax assets and liabilities have been offset where
they relate to income taxes levied by the same taxation authority
and the Company has the legal right and intent to offset.
|
|
|
|
|
|
|
|
|
| |
|
2017 |
|
|
2016 |
|
|
Deferred tax assets
|
|
|
|
|
|
|
|
|
|
Non-capital losses carried
forward
|
|
$ |
5,690 |
|
|
$ |
2,400 |
|
|
Scientific research and experimental development
|
|
|
28 |
|
|
|
28 |
|
|
Financing fees
|
|
|
31 |
|
|
|
— |
|
|
|
|
|
Deferred tax liabilities
|
|
|
|
|
|
|
|
|
|
Biological assets
|
|
|
(986 |
) |
|
|
(18 |
) |
|
Inventory
|
|
|
(1,989 |
) |
|
|
(51 |
) |
|
Equity accounted investments
|
|
|
(153 |
) |
|
|
— |
|
|
Investments
|
|
|
(91 |
) |
|
|
(696 |
) |
|
Property, plant and equipment
|
|
|
(968 |
) |
|
|
(158 |
) |
|
Health Canada licenses
|
|
|
(2,978 |
) |
|
|
(2,962 |
) |
|
|
|
|
|
|
|
|
|
|
Net deferred tax liability
|
|
$ |
(1,416 |
) |
|
$ |
(1,457 |
) |
|
|
|
|
|
|
|
|
|
|
| Summary of movement in net deferred tax liability |
The movement in the net deferred tax liability is
provided below:
|
|
|
|
|
|
|
|
|
| |
|
2017 |
|
|
2016 |
|
|
Balance - beginning of year
|
|
$ |
1,457 |
|
|
$ |
195 |
|
|
Recognized in income
|
|
|
298 |
|
|
|
(568 |
) |
|
Recognized in other comprehensive income
|
|
|
(339 |
) |
|
|
430 |
|
|
Recognized in goodwill
|
|
|
— |
|
|
|
1,400 |
|
|
|
|
|
|
|
|
|
|
|
Balance - end of year
|
|
$ |
1,416 |
|
|
$ |
1,457 |
|
|
|
|
|
|
|
|
|
|
|
| Summary of Net Deferred Tax Asset Not Recognized |
|
|
|
|
|
|
|
|
|
| |
|
2017 |
|
|
2016 |
|
|
Property, plant and equipment
|
|
$ |
684 |
|
|
$ |
— |
|
|
Equity accounted investments
|
|
|
— |
|
|
|
89 |
|
|
Share and debt issuance costs (i)
|
|
|
2,834 |
|
|
|
1,085 |
|
|
Losses carried forward (ii)
|
|
|
7,814 |
|
|
|
3,833 |
|
|
Other investments
|
|
|
— |
|
|
|
6 |
|
| (i) |
Share and debt issuance costs will be fully
amortized in 2022. The remaining deductible temporary differences
may be carried forward indefinitely.
|
| (ii) |
For income tax purposes, the Company has losses
carried forward from prior years which can be used to reduce future
years’ taxable income. These losses expire as follows:
|
|
| Summary of non-capital and farm losses carried forward to future years |
For income tax purposes, the Company
has losses carried forward from prior years which can be used to
reduce future years’ taxable income. These losses expire as
follows:
|
|
|
|
|
| |
|
Non-capital
losses |
|
|
2030
|
|
$ |
32 |
|
|
2031
|
|
|
22 |
|
|
2032
|
|
|
877 |
|
|
2033
|
|
|
3,177 |
|
|
2034
|
|
|
1,782 |
|
|
2035
|
|
|
5,452 |
|
|
2036
|
|
|
6,558 |
|
|
2037
|
|
|
11,383 |
|
|
|
|
|
|
|
|
$ |
29,283 |
|
|
|
|
|
|
|